:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/popsci/popsci-rssapp-infectiousdiseaseadvisor-com-5e79ee0f/ec56e904ac0917104564978bce919e95_wm.png)
Switch to INSTIs May Lead to Increased Diabetes Risk in Patients With HIV
Summary: If you have HIV and switch your medication to a type called INSTIs, you might want to watch your blood sugar. A new study shows that switching to INSTIs—especially from older drugs called protease inhibitors—can increase your risk of getting diabetes.
This risk is highest in the first two years after changing meds, and it can happen even if you don't gain weight. Doctors recommend keeping a close eye on your health and blood sugar levels when making this switch.
Source: Infectious Disease Advisor URL: infectiousdiseaseadvisor.com/news/hiv-insti-switch-diabetes-risk/ (opens in new tab)
Tags
Weight Gain
Nucleosides
Protease Inhibitors
Reverse Transcriptase Inhibitors
Integrases